Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
112.10
+0.56 (0.50%)
Jul 29, 2026, 3:11 PM EDT - Market open
Veradermics Employees
Veradermics had 24 employees as of March 31, 2026. The number of employees increased by 3 or 14.29% since the number was last reported on December 31, 2025.
Employees
24
Change
3
Growth
14.29%
Revenue / Employee
n/a
Profits / Employee
-$4,116,750
Market Cap
4.68B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 24 | 3 | 14.29% |
| Dec 31, 2025 | 21 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| ACADIA Pharmaceuticals | 798 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Dyne Therapeutics | 263 |
| Relay Therapeutics | 193 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
MANE News
- 12 days ago - Veradermics presents data from subgroup analysis of Phase 2/3 VDPHL01 study - TheFly
- 12 days ago - Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302' in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy - Business Wire
- 13 days ago - Veradermics price target raised to $160 from $135 at Citi - TheFly
- 14 days ago - B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating - TipRanks
- 14 days ago - Veradermics rises 13.9% - TheFly
- 14 days ago - Veradermics Transcript: Study result - Transcripts
- 14 days ago - Veradermics Press release: Study result - Filings
- 14 days ago - Veradermics Slides: Study result - Filings